Orthobiologics are substances that orthopaedic surgeons use to help injuries heal more quickly. They are used to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are often made from substances that are naturally found in your body. When they are used in higher concentrations, they may help speed up the healing process. The global Orthobiologics market is expected to enlarge at a significant rate in the forecast period due to increased acceptance of these substances globally.
Presently, there is huge growth in orthopedic injuries including injuries due to road accidents and sports injuries. This key fact is expected to create various opportunities for vendors operating in the global orthobiologics market. As well, increasing cases of spinal fusion surgeries and the growing old age population across the world are projected to fuel the growth of the global orthobiologics market. As per data of Spinal Cord, Inc., the U.S. had 245,000 to 353,000 people living with spinal cord injury in 2017. Furthermore, other factors such as increased obesity problems globally and rising musculoskeletal disorders majorly contribute to the growth of the orthobiologics market. Besides this, growth in inclination towards minimally invasive procedures further rises the opportunities for the global orthobiologics market.
On the other hand, less reimbursement and stringent regulatory requirements may hamper the growth of the orthobiologics market in the forecast period.
Covid-19 Impact on Orthobiologics Market:
In addition, the current Orthobiologics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Orthobiologics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Orthobiologics Market Segment Overview
Based on product, the Viscosupplementation segment has the largest share of the orthobiologics market. This is due to the rise in the prevalence of knee osteoarthritis. Also, the better reimbursement scenario for the products as these is approved by the U.S. FDA further rises the growth of this segment. In addition to this, France has a well-defined reimbursement policy for viscosupplementation products. Moreover, by application, the spinal fusion segment has significant growth in the market. This is mainly due to the rising prevalence of spine and traumatic injuries, sports-related injuries, and accidents.
Orthobiologics Market, By Product
· Bone Morphogenetic Proteins
· Demineralized Bone Matrix
· Synthetic Bone Substitutes
· Viscosupplements
· Allografts
· Stem Cells
· Others
Orthobiologics Market, By Application
· Spinal Fusion
· Trauma Repair
· Reconstructive Surgeries
· Others
Orthobiologics Market, By End-User
· Hospitals
· Orthopedic Clinics
· Others
Orthobiologics Regional Overview
Region-wise, North America accounted for the maximum share of the global orthobiologics market. Factors such as rapid development in the technologies in orthobiologics, growing sports-related injuries, and injuries due to accidents have fueled the growth of the market in this region. Similarly, the Asia Pacific region is expected to have a major share of orthobiologics market. This is due to the increase in orthopedic procedures and surge in the old age population in China and India. Moreover, the market in the Middle East & Africa is projected to rise at a considerable rate due to the increasing old age population in this region.
Orthobiologics Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Orthobiologics Market Competitor overview
Some key developments and strategies adopted by manufacturers in Orthobiologics are highlighted below.
· In July 2021, Recently listed Bioventus Inc has agreed to acquire Misonix Inc for $518 million in a cash-and-stock transaction. Misonix stockholders may elect to receive either 1.6839 Bioventus shares or $28.00 in cash in the transaction.
· In September 2018, NuVasive, Inc.the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced the U.S. commercial launch of three new biologics offerings to include traditional bone allograft, amniotic membrane DS and additional form factors to the current PropelTM DBM product line. This portfolio expansion demonstrates the Company’s strategic efforts to deliver the most differentiated biologics portfolio in the spine industry.
· In March 2018, Synergy Biomedical, LLC, a developer of orthobiologic and biomaterial products, announced that it has received Therapeutic Goods Administration (TGA) clearance in Australia for its bioactive bone graft, BIOSPHERE PUTTY. BIOSPHERE PUTTY is an advanced synthetic bone graft product that has previously received FDA and CE Mark clearances, and has been on the market since 2013.
Orthobiologics Market, Key Players
· Medtronic
· DePuy Synthes (Johnson & Johnson)
· Sanofi
· Seikagaku Corporation
· Stryker
· MTF Biologics
· Bioventus LLC
· Arthrex
· Zimmer Biomet
· RTI Surgical, Inc.
· Alphatec Spine, Inc.
· Exactech, Inc.
· Globus Medical, Inc.
· Integra LifeSciences
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Orthobiologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Bone Morphogenetic Proteins
- 5.2.2. Demineralized Bone Matrix
- 5.2.3. Synthetic Bone Substitutes
- 5.2.4. Viscosupplements
- 5.2.5. Allografts
- 5.2.6. Stem Cells
- 5.2.7. Others
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Spinal Fusion
- 5.3.2. Trauma Repair
- 5.3.3. Reconstructive Surgeries
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By End-User
- 5.4.1. Hospitals
- 5.4.2. Orthopedic Clinics
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Orthobiologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Bone Morphogenetic Proteins
- 6.2.2. Demineralized Bone Matrix
- 6.2.3. Synthetic Bone Substitutes
- 6.2.4. Viscosupplements
- 6.2.5. Allografts
- 6.2.6. Stem Cells
- 6.2.7. Others
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Spinal Fusion
- 6.3.2. Trauma Repair
- 6.3.3. Reconstructive Surgeries
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast – By End-User
- 6.4.1. Hospitals
- 6.4.2. Orthopedic Clinics
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Orthobiologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Bone Morphogenetic Proteins
- 7.2.2. Demineralized Bone Matrix
- 7.2.3. Synthetic Bone Substitutes
- 7.2.4. Viscosupplements
- 7.2.5. Allografts
- 7.2.6. Stem Cells
- 7.2.7. Others
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Spinal Fusion
- 7.3.2. Trauma Repair
- 7.3.3. Reconstructive Surgeries
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast – By End-User
- 7.4.1. Hospitals
- 7.4.2. Orthopedic Clinics
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Orthobiologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Bone Morphogenetic Proteins
- 8.2.2. Demineralized Bone Matrix
- 8.2.3. Synthetic Bone Substitutes
- 8.2.4. Viscosupplements
- 8.2.5. Allografts
- 8.2.6. Stem Cells
- 8.2.7. Others
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Spinal Fusion
- 8.3.2. Trauma Repair
- 8.3.3. Reconstructive Surgeries
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast – By End-User
- 8.4.1. Hospitals
- 8.4.2. Orthopedic Clinics
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Orthobiologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Bone Morphogenetic Proteins
- 9.2.2. Demineralized Bone Matrix
- 9.2.3. Synthetic Bone Substitutes
- 9.2.4. Viscosupplements
- 9.2.5. Allografts
- 9.2.6. Stem Cells
- 9.2.7. Others
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Spinal Fusion
- 9.3.2. Trauma Repair
- 9.3.3. Reconstructive Surgeries
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast – By End-User
- 9.4.1. Hospitals
- 9.4.2. Orthopedic Clinics
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Medtronic
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. DePuy Synthes (Johnson & Johnson)
- 10.6. Sanofi
- 10.7. Seikagaku Corporation
- 10.8. Stryker
- 10.9. MTF Biologics
- 10.10. Bioventus LLC
- 10.11. Arthrex
- 10.12. Zimmer Biomet
- 10.13. RTI Surgical, Inc.
- 10.14. Alphatec Spine, Inc.
- 10.15. Exactech, Inc.
- 10.16. Globus Medical, Inc.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
